Advertisement

Topics

Bristol-Myers Squibb Company Profile

21:16 EST 19th November 2017 | BioPortfolio

At Bristol-Myers Squibb,our mission is to extend and enhance human life by providing the highest-quality pharmaceuticals and health care products.

Location

345 Park Avenue
New York
10154-0037
United States of America

Contact

Phone: 212-546-4000
Email: corporate.communications@bms.com


News Articles [688 Associated News Articles listed on BioPortfolio]

Head-To-Head Survey: Bristol-Myers Squibb (BMY) & Its Competitors

Bristol-Myers Squibb is one of 113 publicly-traded companies in the "Pharmaceuticals" industry, but how does it weigh in compared to its rivals? We will compare Bristol-Myers Squibb to similar busines...

Investment Analysts' Weekly Ratings Updates for Bristol-Myers Squibb

Several brokerages have updated their recommendations and price targets on shares of Bristol-Myers Squibb in the last few weeks: 9/19/2017 - Bristol-Myers Squibb had its "hold" rating reaffirmed by an...

Research Analysts' Weekly Ratings Changes for Bristol-Myers Squibb

A number of firms have modified their ratings and price targets on shares of Bristol-Myers Squibb recently: 7/27/2017 - Bristol-Myers Squibb was given a new $60.00 price target on by analysts at Piper...

Bristol-Myers Squibb To Acquire IFM Therapeutics

NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Company (BMY) and IFM Therapeutics announced the companies have signed an agreement under which Bristol-Myers Squibb will acquire all of the outstand...

Bristol-Myers Squibb Brings Out Its Ace Card In The Midst Of An IDO Inhibitor Battle

Bristol-Myers Squibb released positive results in an early-stage study using an IDO inhibitor drug in combination with Opdivo in both bladder and cervical cancer patients. Recently, Bristol-Myers Squi...

Bristol-Myers Squibb Completes Acquisition of IFM Therapeutics

NewsBristol-Myers Squibb completes previously announced acquisition of IFM Therapeutics. The transaction includes full rights to IFM’s preclinical STING and NLRP3 agonist programs focused on enhanci...

Bristol-Myers Squibb to Acquire IFM Therapeutics, Strengthening its Oncology Pipeline Focus on Innate Immunity

NEW YORK & BOSTON–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) and IFM Therapeutics (IFM) announced today that the companies have signed a definitive agreement under which B...

Bristol-Myers Squibb Collaborates on Cancer Treatment Delivery Method

NewsBristol-Myers Squibb and Halozyme enter global collaboration and license agreement for Enhanze technology. The method enhances patient care through delivery of cancer treatments by subcutaneous in...

PubMed Articles [93 Associated PubMed Articles listed on BioPortfolio]

Treatment of Ipilimumab-Induced Vogt-Koyanagi-Harada Syndrome With Oral Dexamethasone.

The author presents a retrospective case report of a 54-year-old male with ipilimumab (Yervoy; Bristol-Myers Squibb, New York City, NY)-induced Vogt-Koyanagi-Harada Disease (VKH), which consisted of u...

A Systematic Review and Pooled Analysis of Select Safety Parameters Among Normal Healthy Volunteers Taking Placebo in Phase 1 Clinical Trials.

A systematic review of the Bristol-Myers Squibb normal healthy volunteers (NHVs) database identified phase 1 trials that included NHVs administered placebo with the aim of characterizing normal inter-...

Prediction of Delayed Colonic Transit Using Bristol Stool Form and Stool Frequency in Eastern Constipated Patients: A Difference From the West.

The correlation between the Bristol stool form scale (BSFS) and colonic transit time (CTT) has been reported in Western populations. Our study aims to study the relationship between BSFS, stool freque...

Test-retest reliability and smallest detectable change of the Bristol Impact of Hypermobility (BIoH) questionnaire.

The Bristol Impact of Hypermobility (BIoH) questionnaire is a patient-reported outcome measure developed in conjunction with adults with Joint Hypermobility Syndrome (JHS). It has demonstrated strong ...

Review of Article: Leeper, N.J., Myers, J., Zhou, M., Nead, K.T., Syed, A., Kojima, Y. … Cooke, J.P. (2013). Exercise capacity is the strongest predictor of mortality in patients with peripheral arterial disease. Journal of Vascular Surgery, 57, 728-33.

Clinical Trials [69 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Prodactariv 60 mg F.C.T (International Drug Agency for Pha...

Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Daktavira 60 mg film coated tablets ( European Egyptian Ph...

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects

- Objective: - A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Co...

Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions

The objective of this study is to assess the single - dose relative bioavailability of Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg cefprozil tablets, under fed conditions.

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions

To compare the single-dose bioavailability of Par and Bristol-Myers Squibb Buspirone HCl Tablets

Companies [118 Associated Companies listed on BioPortfolio]

Pfizer Inc. & Bristol-Myers Squibb

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. Th...

Bristol-Myers Squibb and Pfizer

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. Th...

Bristol-Myers Squibb Company and Pfizer Inc.

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize Eliquis, an oral anticoagulant discovered by Bristol-Myers Squibb. Thi...

Bristol-Myers Squibb Company & Pfizer Inc.

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize ELIQUIS, an investigational oral anticoagulant discovered by Bristol-M...

Exelixis, Inc. and Bristol-Myers Squibb Company

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases....

More Information about "Bristol-Myers Squibb" on BioPortfolio

We have published hundreds of Bristol-Myers Squibb news stories on BioPortfolio along with dozens of Bristol-Myers Squibb Clinical Trials and PubMed Articles about Bristol-Myers Squibb for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bristol-Myers Squibb Companies in our database. You can also find out about relevant Bristol-Myers Squibb Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record